Funded Grants
PI Name |
Organization | Title | Project Number | Fiscal Year | Major Program/Research Group |
|---|---|---|---|---|---|
| Clapper, Margie | RESEARCH INST OF FOX CHASE CAN CTR | A Novel Non-COX Inhibitory Sulindac Derivative for Colorectal Cancer Chemoprevention with Selective PDE10 and Wnt/b-Catenin Inhibitory Activity | 261201500032I-0-26100003-1 | 2018 | PREVENT Cancer Preclinical Drug Development Program |
| Clapper, Margie L. | Research Inst Of Fox Chase Can Ctr | Targeted Chemoprevention of Flat and Polypoid Colitis-associated Dysplasias | 5R01CA183301-05 | 2019 | Chemopreventive Agent Development |
| Clinton, Steven K | Ohio State University | Modulation of antitumor immunity by dietary soy and its isoflavone constituents | 5R01CA169363-06 | 2018 | Nutritional Science |
| Clinton, Steven K | Ohio State University | Translating Novel Antitumor Targets of Vitamin E into New Chemopreventive Agents | 5R01CA172576-05 | 2018 | Chemopreventive Agent Development |
| Cohen, Lorenzo | University Of Tx Md Anderson Can Ctr | Community-Based, Phase III Trial of acupuncture to treat chronic Xerostomia | 4R01CA160880-05 | 2017 | Community Oncology and Prevention Trials, Supportive Care and Symptom Management, Oral Complications, Nutrition |
| Cole, Peter D | Rbhs -Cancer Institute Of New Jersey | Pathophysiology of Chemotherapy-Induced Cognitive Deficits in Juvenile Rats | 7R01CA182284-06 | 2018 | Community Oncology and Prevention Trials, Supportive Care and Symptom Management, Cognitive Dysfunction |
| Cole, Peter D | Rbhs -Cancer Institute Of New Jersey | Identifying children with subclinical neurocognitive decline and susceptibility to oxidative damage during the early months of therapy for ALL | 5R01CA220568-02 | 2019 | Community Oncology and Prevention Trials, Supportive Care and Symptom Management, Pediatrics/Adolescents/Young Adult, Cognitive Dysfunction |
| Coleman, William B | American Society/Investigative Pathology | 2019 Annual Meeting of the American Society for Investigative Pathology | 1R13CA239538-01 | 2019 | Cancer Biomarkers |
| Conklin, Matthew W | University Of Wisconsin-Madison | Collagen structural changes as an early biomarker for breast carcinoma | 5R01CA199996-05 | 2019 | Cancer Biomarkers |
| Conklin, Heather M | St. Jude Children'S Research Hospital | Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Low Grade Glioma | 5R21CA218625-02 | 2018 | Community Oncology and Prevention Trials, Supportive Care and Symptom Management, Cognitive Dysfunction |
| Conley, Yvette P | University Of Pittsburgh At Pittsburgh | Epigenomics of Neurocognitive Function in Breast Cancer | 5R01CA221882-02 | 2019 | Community Oncology and Prevention Trials, Supportive Care and Symptom Management, Cognitive Dysfunction |
| Cooperberg, Matthew R | University Of California, San Francisco | Improving Prostate Cancer Outcome Prediction Through Noninvasive exRNA Assessment | 5R01CA198145-04 | 2019 | Cancer Biomarkers |
| Cope, Timothy C | Georgia Institute Of Technology | Novel Path to Chronic Sensorimotor Dysfunction and Treatment for Chemotherapy | 5R01CA221363-02 | 2019 | Community Oncology and Prevention Trials, Supportive Care and Symptom Management, Physical Functioning |
| Crandall, Jill P | Albert Einstein College Of Medicine | 20/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project | 5U01DK048349-29 | 2020 | Breast and Gynecologic Cancer, DPPOS Study |
| Crew, Katherine D | Columbia University Health Sciences | Increasing breast cancer chemoprevention in the primary care setting | 5R01CA177995-05 | 2018 | Breast and Gynecologic Cancer |